DECisive Intracoronary PHysiology and Imaging in the Evaluation and Reclassification of Non-culprit Lesions in Acute Coronary Syndrome
NCT07548554 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-04-23
Summary
Despite all advances in diagnostic and therapeutic methods over the past century, ischemic heart disease (IHD) remains a leading cause of mortality and morbidity worldwide. IHD develops as a result of reversible or irreversible impairment of myocardial perfusion in acute or chronic settings. This perfusion abnormality most commonly arises from compromise of epicardial coronary artery patency due to stenosis, occlusion, or vasomotor abnormalities. Structural and/or functional alterations in the microcirculation may also contribute to impaired myocardial perfusion.
Conditions in which myocardial perfusion is acutely compromised are classified as acute coronary syndromes (ACS), whereas reversible ischemia developing on a chronic basis is evaluated under the umbrella of chronic coronary syndromes (CCS). In the assessment of epicardial (macrovascular) or microvascular pathologies leading to ischemia in CCS, angiography, a macroscopic lumenographic method, is often insufficient. Intracoronary pressure and flow measurements are required to determine the impact of angiographically detected epicardial lesions on coronary blood flow, perfusion pressure, and consequently myocardial perfusion. These measurements are referred to as invasive intracoronary physiology (IIP).
Current guidelines recommend that decisions regarding revascularization of intermediate epicardial lesions should be based on IIP. Revascularization guided by IIP is associated with reduced mortality and morbidity, along with a lower stent burden. IIP can be performed using pressure-based, flow-based, or combined strategies. Recent multinational studies indicate that strategies integrating both flow and pressure parameters achieve better clinical outcomes with fewer interventions and reduced stent implantation compared to pressure-only approaches. Indeed, in cases where coronary flow and flow reserve are preserved, abnormalities in pressure parameters alone may not justify revascularization.
Nevertheless, lesions deemed not to be associated with reversible ischemia based on IIP may still pose a risk due to plaque erosion/rupture and subsequent thrombotic cascades that can acutely compromise the lumen. Many acute coronary syndromes arise from lesions that are hemodynamically insignificant (i.e., do not affect flow) and unrelated to reversible ischemia in the CCS setting, but which undergo sudden near-total or total occlusion.
The histopathological characteristics of any coronary lesion can be evaluated using intracoronary imaging techniques. Intracoronary Optical Coherence Tomography (IC-OCT) is a high-resolution, real-time imaging modality that quantitatively assesses lipid-rich plaque content, evaluates the thickness and stability of the fibrous cap separating this content from the lumen, and provides detailed information regarding minimal lumen area, lesion morphology, surface characteristics, presence of erosion, and plaque vulnerability to rupture. IC-OCT can identify lesions that are hemodynamically insignificant yet may benefit from revascularization and have the potential to cause ACS.
Combined evaluation using IC-OCT and IIP enables an integrated assessment of both the relationship with chronic reversible perfusion impairment and the risk of precipitating ACS for each lesion and coronary segment, thereby facilitating optimal revascularization strategies. Despite the available evidence and guideline recommendations in CCS, the use of IC-OCT and IIP in the context of ACS remains limited due to procedural challenges and variability in practical application. These methods are not routinely recommended in guidelines and, in some cases, are even discouraged.
However, the optimal strategy for revascularization of non-culprit lesions in ACS remains uncertain, and no consensus has yet been established. Patients with ACS are at increased risk for recurrent events arising from all coronary lesions. Therefore, accurate evaluation and preventive revascularization strategies for these lesions are expected to provide substantial benefit. Our study aims to reclassify and characterize non-culprit lesions in patients with ACS using combined IC-OCT and IIP assessment.
Conditions
- Coronary Artery Disease
- Acute Coronary Syndromes (ACS)
- Optic Coherence Tomography
- Fractional Flow Reserve
Interventions
- DIAGNOSTIC_TEST
-
Intracoronary Physiology
The evaluation of non-culprit lesion with the intra-coronary physiology
- DIAGNOSTIC_TEST
-
Intracoronary imaging
The evaluation of non-culprit lesion with the intra-coronary imaging (OCT)
Sponsors & Collaborators
-
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-14
- Primary Completion
- 2027-04-30
- Completion
- 2027-04-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT01143454 ·Status: RECRUITING
-
Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
NCT03338504 ·Status: COMPLETED
-
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
NCT06409585 ·Status: RECRUITING
-
Noninvasive Imaging of Heart Failure: A Pilot Study
NCT01160471 ·Status: COMPLETED
-
Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI
NCT01655043 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Value of Right Ventricular Myocardial Strain in Patients With Acute Myocardial Infarction
NCT05404555 ·Status: UNKNOWN
-
The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy
NCT05026112 ·Status: UNKNOWN
-
Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.
NCT05701410 ·Status: UNKNOWN ·Phase: NA
-
Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI)
NCT01049997 ·Status: COMPLETED
-
Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
NCT02462213 ·Status: WITHDRAWN
-
Assessment of Myocardial Viability Using Multidetector Computed Tomography
NCT00285064 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Manifestation of Inflamatory Bowel Disease Patient ( Tissue Doppler Echocardiography and Cardiac MRI )
NCT04656015 ·Status: UNKNOWN
-
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661 ·Status: RECRUITING
-
Molecular Imaging of Primary Amyloid Cardiomyopathy
NCT02641145 ·Status: RECRUITING ·Phase: NA
-
Intracardiac Flow Assessment in Cardiac Amyloidosis
NCT05379101 ·Status: RECRUITING
-
CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
NCT04862273 ·Status: COMPLETED
-
Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology
NCT04983433 ·Status: UNKNOWN
-
Cardiac MRI in Front Line for the Diagnosis of Coronary Artery Disease as the Etiology of Left Ventricular Dysfunction
NCT03231189 ·Status: COMPLETED
-
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
NCT00181233 ·Status: RECRUITING
-
Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy
NCT06689098 ·Status: COMPLETED
-
Evaluation of Infarct Size With 3D Rotational Angiography
NCT02857985 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging of the Blood Vessels of the Heart
NCT00001638 ·Status: COMPLETED
-
Validation of Different Diagnostic Modalities in the Detection of Cardiac Amyloidosis Among Patients With "Red Flags"
NCT06175858 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MRI of Myocardial Infarction
NCT03531151 ·Status: COMPLETED
-
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
NCT04537741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA